Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
Clinical Considerations and Opportunities in Gene Therapy
Track:
Educational Sessions (CE)
Program Code: 254-L01
Date: Wednesday, December 9, 2009
Time: 8:00 AM to 9:45 AM EST
Location:
2204 - Titian
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Susan Goodin, PharmD, BCOP, Associate Director, Clinical Trials and Therapeutics; and Professor of Medicine, Robert Wood Johnson Medical School
PRESENTER(S):
Dr. Daniel Buffington, PharmD, MBA, President and CEO, Clinical Pharmacology Services, Inc
Susan Goodin, PharmD, BCOP, Associate Director, Clinical Trials and Therapeutics; and Professor of Medicine, Robert Wood Johnson Medical School Heidi Gunderson, PharmD, BCOP, Pharmacy Coordinator Hematology/Oncology Disease Management, Mayo Clinic
Description
Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists Section Advisory Group on Gene Therapy
ACPE Activity #204-000-09-254-L01P
1.75 Contact Hours / Knowledge-based
Educational Content: Level 2
Moderator: Susan Goodin, PharmD, BCOP, Associate Director, Clinical Trials and Therapeutics; and Professor of Medicine, Robert Wood Johnson Medical School, New Brunswick, NJ
8:00 a.m. – 8:05 a.m.
Announcements
8:05 a.m. – 8:15 a.m.
Overview of Results from the ASHP Gene Therapy Survey
Susan Goodin
8:15 a.m. – 8:20 a.m.
Questions, Answers, and Discussion
8:20 a.m. – 8:50 a.m.
Educating Patients about Gene Therapy: Information and Tools
Daniel E. Buffington, PharmD, MBA, President and CEO, Clinical Pharmacology Services, Inc., Tampa, FL
8:50 a.m. – 8:55 a.m.
Questions, Answers, and Discussion
8:55 a.m. – 9:15 a.m.
Recent Data on Gene Therapy and Prostate Cancer
Heidi D. Gunderson, PharmD, BCOP, Pharmacy Coordinator Hematology/Oncology Disease Management, Mayo Clinic, Rochester, MN; and Instructor in Pharmacy, College of Medicine, Mayo School of Health Related Sciences, Rochester, MN
9:15 a.m. – 9:20 a.m.
Questions, Answers, and Discussion
9:20 a.m. – 9:40 a.m.
Recent Data on Gene Therapy and Cardiovascular Disease
Orly Vardeny, PharmD, Assistant Professor, University of Wisconsin, Madison
9:40 a.m. – 9:45 a.m.
Questions, Answers, and Discussion
Learning Objectives:
ACPE Activity #204-000-09-254-L01P
1.75 Contact Hours / Knowledge-based
Educational Content: Level 2
Moderator: Susan Goodin, PharmD, BCOP, Associate Director, Clinical Trials and Therapeutics; and Professor of Medicine, Robert Wood Johnson Medical School, New Brunswick, NJ
8:00 a.m. – 8:05 a.m.
Announcements
8:05 a.m. – 8:15 a.m.
Overview of Results from the ASHP Gene Therapy Survey
Susan Goodin
8:15 a.m. – 8:20 a.m.
Questions, Answers, and Discussion
8:20 a.m. – 8:50 a.m.
Educating Patients about Gene Therapy: Information and Tools
Daniel E. Buffington, PharmD, MBA, President and CEO, Clinical Pharmacology Services, Inc., Tampa, FL
8:50 a.m. – 8:55 a.m.
Questions, Answers, and Discussion
8:55 a.m. – 9:15 a.m.
Recent Data on Gene Therapy and Prostate Cancer
Heidi D. Gunderson, PharmD, BCOP, Pharmacy Coordinator Hematology/Oncology Disease Management, Mayo Clinic, Rochester, MN; and Instructor in Pharmacy, College of Medicine, Mayo School of Health Related Sciences, Rochester, MN
9:15 a.m. – 9:20 a.m.
Questions, Answers, and Discussion
9:20 a.m. – 9:40 a.m.
Recent Data on Gene Therapy and Cardiovascular Disease
Orly Vardeny, PharmD, Assistant Professor, University of Wisconsin, Madison
9:40 a.m. – 9:45 a.m.
Questions, Answers, and Discussion
Learning Objectives:
- Discuss the recent data involving gene therapy as it pertains to cancer and cardiovascular disease.
- Discuss the results of a recent ASHP Gene Therapy Survey and describe the current needs of health-system pharmacy as it relates to gene therapy.
- Identify and discuss best practices for patient education regarding gene therapy.
This session is a part of:
Handout Online
